PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase

Amit Gupta1, Chinmoy Sankar Dey

  • 1Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sec. 67, S.A.S. Nagar, Punjab 160 062, India.

Insights

Focal adhesion kinase (FAK) regulates insulin signaling. Insulin resistance causes FAK dephosphorylation via PTEN and SHIP2 phosphatases, impairing glucose uptake in muscle cells.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Research

Background:

  • Focal adhesion kinase (FAK) plays a role in insulin signaling.
  • Insulin resistance is linked to decreased FAK tyrosine phosphorylation in skeletal muscle.
  • The precise mechanism of FAK dephosphorylation in insulin resistance is not fully understood.

Purpose of the Study:

  • To investigate the cellular mechanism of FAK dephosphorylation in C2C12 skeletal muscle cells under insulin resistance.
  • To identify the phosphatases responsible for FAK dephosphorylation in this context.

Main Methods:

  • In vitro studies using C2C12 skeletal muscle cells.
  • Analysis of FAK tyrosine phosphorylation levels.
  • Investigation of phosphatase activity, specifically PTEN and SHIP2.

Main Results:

  • Insulin resistance induced dephosphorylation of FAK in C2C12 cells.
  • PTEN and SHIP2 phosphatases were identified as key mediators of FAK dephosphorylation.
  • Upregulation of PTEN and SHIP2 under insulin resistance impairs insulin signaling via FAK.

Conclusions:

  • PTEN and SHIP2 are responsible for FAK dephosphorylation in insulin-resistant skeletal muscle cells.
  • FAK acts as a crucial mediator for PTEN and SHIP2 in regulating insulin signaling.
  • This study elucidates a molecular mechanism underlying insulin resistance in skeletal muscle.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...